Cardiovascular Prosthetic Devices Market by Type (Cardiac prosthetic devices, Vascular Prosthetic Devices), by End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Cardiovascular prosthetic devices are medical devices that are used to replace or supplement damaged or missing heart tissue. These can be used to replace a damaged heart valve, divert blood flow, or assist with cardiac pacing and other functions. The devices are typically implanted by a cardiac surgeon and can have a significant impact on quality of life.

Increase in the number of product launches and product approvals for cardiovascular prosthetic devices and rise in the number of adoption of strategies such as collaboration, acquisition, and partnership by market players drive the market growth. For instance, in September 2021, Abbott Laboratories, pharmaceutical and medical equipment manufacturing company, announced that the U.S. Food and Drug Administration (FDA) has approved Epic Plus and Epic Plus Supra Stented Tissue Valves of the company to improve therapy options for people with aortic or mitral valve disease.